Intestinal drug absorption and bioavailability: beyond involvement of single transport function

Characterization of hepatocellular carcinoma patient-derived organoids from patients receiving transarterial chemoembolization as a model for preclinical drug response assessment.

Scientific reports·2026

Column coupling for chiral LC-MS separation resolves triacylglycerol enantiomers and regioisomers in complex samples without flow recycling.

Talanta·2026

Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma.

Neoplasia (New York, N.Y.)·2026

The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant).

Molecular pharmaceutics·2026

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling.

FEBS open bio·2026

CombiCTx: screening diffusion gradients of anti-cancer drug combinations.

Lab on a chip·2026

Amorphous particles enhance oral exposure-a case study of a poorly soluble compound in preclinical, toxicology and early clinical studies.

The Journal of pharmacy and pharmacology·2026

Neuroprotective euglobals from Eucalyptus tereticornis Smith. leaves: quantification, network pharmacology-guided in silico analysis, and experimental validation.

The Journal of pharmacy and pharmacology·2026

A review of natural plant polysaccharides: the relationship between extraction methods, physicochemical properties, structures, and biological activity.

The Journal of pharmacy and pharmacology·2026

Acute intravenous antihypertensive and in vitro vasorelaxant effect of the hydroalcoholic stem bark extract of Hymenaea rubriflora Ducke in spontaneously hypertensive rats.

The Journal of pharmacy and pharmacology·2026

Shanhuang Jiangzhi tablets mitigate atherosclerosis by modulating macrophage polarization and inhibiting foam cell formation via the ROS/TLR4/NF-κB pathway.

The Journal of pharmacy and pharmacology·2026

Nanocarrier-based targeting strategies in epilepsy: addressing pathophysiological barriers.

The Journal of pharmacy and pharmacology·2026

Reliable Apparent Permeability Prediction Through Benchmarking, Stability, Uncertainty Quantification, and Explainable Machine Learning.

CPT: pharmacometrics & systems pharmacology·2026

Is drug development in India is responsive to disease burden: A descriptive study.

Perspectives in clinical research·2026

Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.

Antibody therapeutics·2026

Lurasidone hydrochloride-loaded microparticle-based long-acting injectable: formulation optimisation, characterisation, and payload release kinetics-a proof of concept study.

Journal of microencapsulation·2026

Exploring New Treatment Strategies for Endometriosis-Narrative Review.

International journal of molecular sciences·2026

Initial Molecular Detection of Membrane Damage in Post-Golgi Compartments.

Cells·2026

Related Experiment Videos

Intestinal drug absorption and bioavailability: beyond involvement of single transport function

Related Concept Videos

Characterization of hepatocellular carcinoma patient-derived organoids from patients receiving transarterial chemoembolization as a model for preclinical drug response assessment.

Column coupling for chiral LC-MS separation resolves triacylglycerol enantiomers and regioisomers in complex samples without flow recycling.

Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma.

The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant).

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling.

CombiCTx: screening diffusion gradients of anti-cancer drug combinations.

Amorphous particles enhance oral exposure-a case study of a poorly soluble compound in preclinical, toxicology and early clinical studies.

Neuroprotective euglobals from Eucalyptus tereticornis Smith. leaves: quantification, network pharmacology-guided in silico analysis, and experimental validation.

A review of natural plant polysaccharides: the relationship between extraction methods, physicochemical properties, structures, and biological activity.

Acute intravenous antihypertensive and in vitro vasorelaxant effect of the hydroalcoholic stem bark extract of Hymenaea rubriflora Ducke in spontaneously hypertensive rats.

Shanhuang Jiangzhi tablets mitigate atherosclerosis by modulating macrophage polarization and inhibiting foam cell formation via the ROS/TLR4/NF-κB pathway.

Nanocarrier-based targeting strategies in epilepsy: addressing pathophysiological barriers.

Reliable Apparent Permeability Prediction Through Benchmarking, Stability, Uncertainty Quantification, and Explainable Machine Learning.

Is drug development in India is responsive to disease burden: A descriptive study.

Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.

Lurasidone hydrochloride-loaded microparticle-based long-acting injectable: formulation optimisation, characterisation, and payload release kinetics-a proof of concept study.

Exploring New Treatment Strategies for Endometriosis-Narrative Review.

Initial Molecular Detection of Membrane Damage in Post-Golgi Compartments.

Related Experiment Videos

Intestinal drug absorption and bioavailability: beyond involvement of single transport function

Related Concept Videos

Related Articles